Download as pdf or txt
Download as pdf or txt
You are on page 1of 16

Close this window to return to IVIS

www.ivis.org

International Congress of
the Italian Association of Companion
Animal Veterinarians

2 -  May, 201
Rimini, Italy

Next Congress :

SCIVAC International Congress


MaU -, 201 - 3LVD, Italy

Reprinted in IVIS with the permission of the Congress Organizers


69° CONGRESSO INTERNAZIONALE MULTISALA SCIVAC
RIMINI 27-29 MAGGIO 2011
Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

Uveal Disease: from Clinical Case to Diagnosis


and Therapy
David Donaldson
BVSc (Hons) DipECVO MRCVS, Animal Health Trust, Newmarket, Suffolk, UK

• What is the uvea?


→ vascular tunic of the eye – choroid(c), ciliary body (cb) & iris (i)
→ contains large capillary beds
→ major site of ocular lymphoid tissue
→ intimate association of choroid and retina

These characteristics help explain the pathogenesis of disease affecting the uvea:
→ blood borne elements trapped within the uveal capillary beds (e.g. micro – organisms, neoplastic cells) may initiate uveitis
→ the uvea is the location of both specific and non specific immunological reactions involving the eye
→ inflammation of the choroid is always associated with inflammation of the retina i.e. chorio-retinitis

• What is the blood – ocular barrier?

• A set of structures which prevents large, high-molecular-weight proteins from entering the intra-ocular fluid
• The capillaries of the iris are non fenestrated and are an important part of the blood ocular barrier
• Disruption of this barrier (e.g. uveitis, neoplasia) leads to large molecules such as lipoproteins entering the normally clear
fluid of the eye

SCIVAC International Congress 2011 - Rimini, Italy


136
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

Lipid aqueous in a cat – large lipoproteins cannot normally pass into the anterior chamber due to the non-fenestrated
structure of iris capillaries – the presence of lipid aqueous indicates breakdown of this barrier.

• In contrast to the iris the capillaries of the choroid are considered to be more “leaky”. Leakage from the choroidal vessels
will lead to fluid accumulating under the retina, which may lead to detachment of the retina.
• The fluid may be serous, transudate or exudate or if the capillaries are severely disrupted blood - some idea of the type of
fluid present is usually possible if it is visible through the semitransparent retina
• the intimate contact between the choroid and retina means inflammation of the choroid will always be associated with con-
current inflammation of the retina

Serous retinal detachments in a dog – the reti-


na (x) is detached and coming anterior into the
vitreous, (note deviation of the blood vessels).

UVEITIS

• Uveitis may be classified on the basis of:


• Anatomical location (e.g. anterior vs. posterior)
• Duration (acute vs. chronic) (chronic > 3 months)
• Aetiopathogenesis (exogenous vs. endogenous)

• In the context of this discussion division of uveitis based on pathogenesis is useful in determining which diagnostic tests
should be considered.
→ exogenous uveitis - causes include trauma (blunt or penetrating) and corneal ulceration
→ endogenous uveitis - develops from within the eye or from the bloodstream
• The initial assessment of a uveitis patient includes taking a thorough history, physical and ophthalmic examinations.

SCIVAC International Congress 2011 - Rimini, Italy


137
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS
• Exogenous causes of uveitis including trauma (blunt or penetrating) and corneal ulceration, are usually diagnosed on oph-
thalmic examination.
• It is worth noting that occasionally penetrating injuries are not obvious, especially if the wound has occurred through the
conjunctiva/sclera rather than the cornea or has involved the posterior aspects of the globe.
• These cases are unilateral and frequently present with severe panuveitis. In such cases the history may be suggestive (e.g.
recent maxillary molar tooth extraction followed by severe unilateral uveitis, or recent history of a cat fight or gunshot
wounds in which adnexal injury may have been noted but no overt corneal penetration was apparent.
• In such cases the ocular media are frequently opaque preventing examination of the posterior segment.
• Initial investigations are therefore usually directed towards imaging the ocular, orbital and adnexal structures; radiography
and ultrasonography being the most commonly utilized in the primary setting.

CLINICAL CASE: 5yo MN X bred

• History
• painful right eye after walk
• something protruding from eye
• previous medical history (PMH) – nothing significantl
• previous ophthalmic history (POH) - nothing significantl

What is your diagnosis?


…………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………
Will uveitis be present in this case and if so would you classify it as endogenous or exogenous uveitis?
…………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………
What other ocular structures may have been damaged with this injury and how significant are they to the manage-
ment and prognosis of the condition?
…………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………
Outline your approach to investigation and management of this case?
…………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………

SCIVAC International Congress 2011 - Rimini, Italy


138
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

What is your diagnosis?


Penetrating corneal foreign body

Will uveitis be present in this case and if so would you classify it as endogenous or
exogenous uveitis?
Yes - uveitis will be present in any situation where the globe is perforated due to breakdown of the blood ocular barrier.
Exogenous uveitis will be present.

What other ocular structures may have been damaged with this injury and how
significant are they to the management and prognosis of the condition?
Lens & posterior segment damage (ciliary body, retina, posterior ocular coats)
If the lens capsule has been ruptured phacoclastic lens induced uveitis (LIU) will develop. Antigenic lens protein is released
causing intense uveitis. In cases suffering from LIU secondary to cat scratch intensive medical systemic and topical anti-
inflammatory has been shown to have a better outcome than intraocular surgery. This has not been showed in intraocular
foreign bodies. Retinal damage associated with perforation or tearing is likely to lead to retinal detachment. Inoculation of
bacteria and or fungi into the posterior segment increases the risk of intractable endophthalmitis

Outline your approach to investigation and management of this case?


Assessment of intraocular damage- some assessment may be possible if the patient is calm and co-operative, in this case
general anaesthesia is needed for FB removal
For examination mydriasis (tropicamide or atropine – preservative free)
Focal light and magnification - assess intraocular damage / rule out other foreign bodies
If it is not possible to assess these structures due to opacity of the ocular media ocular ultrasound should be used. Do not
use ultrasound gel if globe is not intact, a temporal approach to the globe in these cases might be useful.

Medical treatment
Small wounds which have sealed may be treated medically with cage rest
All cases → assume intraocular microbial inoculation and cover for endophthalmitis and secondary uveitis
Systemic broad spectrum antibiotics e.g. amoxicillin – clavulanic acid
Systemic non-steroidals anti-inflammatories
Cyclopegic/ mydriatic → topical 1% atropine → ↓ ciliary spasm & to prevent synechiae
Topical broad spectrum with antibiotics with good corneal penetration

Surgical treatment
Direct corneal suturing – only used if the defect is very small – otherwise tension on the sutures is likely to lead to wound
breakdown and excessive astigmatism
Rotational conjunctival pedicle
Lens capsule rupture - lens extraction needs to be considered depending on the size of the lesion

Endogenous uveitis develops from within the eye or from the bloodstream. The known and proposed causes of canine and
feline uveitis are listed in Table 1 and Table 2 respectfully.

• Feline uveitis

• The majority of feline uveitis cases will have no history or clinical findings suggestive of an exogenous cause and consider-
ation of the endogenous causes of uveitis (Table 1) will be necessary.
• Excluding cases of uveitis associated with intraocular neoplasia, lens disease, lipid aqueous or the rare situation where an
intraocular parasite is directly visualized (e.g. ophthalmomyiasis interna), there are no pathognomonic clinical ophthalmic
changes associated with endogenous uveitis in the cat.
• Independent of aetiology, aqueous flare, iritis, keratic precipitates, hyphaema and hypopyon commonly develop in the ante-
rior chamber, whilst posterior uveitis presents with signs of choroidal and retinal inflammation including exudates, haemor-
rhage and retinal detachment.

SCIVAC International Congress 2011 - Rimini, Italy


139
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

TABLE 1 - Feline Uveitis: Known or Proposed Causes

INFECTIOUS

PROTOZOAL TOXOPLASMA GONDII


LEISHMANIA DONOVANI

VIRAL FELINE LEUKEMIA VIRUS (FELV)


FELINE IMMUNODEFICIENCY VIRUS (FIV)
FELINE INFECTIOUS PERITONITIS VIRUS (FIP)
FELINE HERPESVIRUS 1 (FHV-1))

BACTERIAL BARTONELLA HENSELAE


MYCOBACTERIUM SPP
BACTERIAL INFECTIONS CAUSING SEPTICAEMIA, ENDOTOXAEMIA,
EXOTOXAEMIA OR IMMUNE COMPLEX DEPOSITION
(E.G. ENDOCARDITIS, PYELONEPHRITIS AND DISCOSPONDYLITIS)

MYCOSES CRYPTOCOCCUS NEOFORMANS


HISTOPLASMA CAPSULATUM
BLASTOMYCES DERMATITIDES
COCCIDIOIDES IMMITIS
CANDIDA ALBICANS

PARASITIC OPHTHALMOMYIASIS INTERNA POSTERIOR (DIPTERA SP.)


OCULAR FILARIASIS (DIROFILARIA IMMITIS)
OCULAR LARVAL MIGRANS (TOXOCARA SPP)

IMMUNE-MEDIATED POORLY DEFINED GROUP LIKELY TO INCLUDE MANY AUTOIMMUNE


DISEASES TO A VARIETY OF ENDOGENOUS ANTIGENS
(E.G. RETINAL-S ANTIGEN) THAT EITHER INITIATE OR PERPETUATE UVEITIS

LENS CATARACTS (LENS-INDUCED UVEITIS, PHACOLITIC UVEITIS)


LENS RUPTURE (PHACOCLASTIC UVEITIS)

NEOPLASIA PRIMARY (MELANOMA)


SECONDARY NEOPLASIA (LYMPHOSARCOMA MOST COMMON)
NON-OCULAR NEOPLASIA (PARANEOPLASTIC SYNDROMES)

METABOLIC HYPERLIPIDAEMIA

VASCULAR HYPERTENSION
TOXAEMIA
ANAEMIA
HYPERVISCOSITY SYNDROMES
BLEEDING DIATHESIS

SCIVAC International Congress 2011 - Rimini, Italy


140
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

TABLE 2 - Canine Uveitis: Known or Proposed Causes

INFECTIOUS

PROTOZOAL LEISHMANIA DONOVANI


TOXOPLASMA GONDII
RICKETTSIAL
EHRLICHIA CANIS OR PLATYS

VIRAL ADENOVIRUS INFECTION (INCLUDING POSTVACCINAL “BLUE-EYE”)


DISTEMPER VIRUS
HERPES VIRUS
RABIES

BACTERIAL BRUCELLA CANIS


BORRELIA BURGDORFERI (I.E., LYME DISEASE)
LEPTOSPIRA SP.
SEPTICEMIA OF ANY CAUSE

MYCOSES BLASTOMYCES DERMATITIDIS


COCCIDIOIDES IMMITIS
CRYPTOCOCCUS NEOFORMANS
HISTOPLASMA CAPSULATUM
OTHER MYCOSES

PARASITIC OPHTHALMOMYIASIS INTERNA POSTERIOR (DIPTERA SP.)


OCULAR FILARIASIS (DIROFILARIA IMMITIS)
OCULAR LARVAL MIGRANS (TOXOCARA AND BALISASCARIS SP.)

ALGAL PROTOTHECA SPP.

IMMUNE-MEDIATED IMMUNE-MEDIATED THROMBOCYTOPENIA


IMMUNE-MEDIATED VASCULITIS
UVEODERMATOLOGIC SYNDROME (SIMILAR TO HUMAN VOGT-
KOYANAGI-HARADA)

LENS CATARACTS (LENS-INDUCED UVEITIS)


LENS RUPTURE (PHACOCLASTIC UVEITIS)

NEOPLASIA / PROLIFERATIVE HISTIOCYTIC PROLIFERATIVE DISEASE


GRANULOMATOUS MENINGOENCEPHALITIS (FORMERLY RETICULOSIS)
PRIMARY (MELANOMA)
SECONDARY NEOPLASMS (LYMPHOSARCOMA MOST COMMON)

METABOLIC DIABETES MELLITUS (PARTICULARLY DIABETIC CATARACT-INDUCED UVEITIS)


HYPERLIPIDEMIA

VASCULAR /HAEM HYPERTENSION


TOXAEMIA
ANAEMIA
HYPERVISCOSITY SYNDROMES
BLEEDING DIATHESIS

SCIVAC International Congress 2011 - Rimini, Italy


141
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

• Cases where the cause of an endogenous uveitis may be apparent in the cat
→ intraocular neoplasia
→ lens disease
→ lipid aqueous

• Feline diffuse iris melanoma is the most common primary neoplasm of cats and usually presents as a diffuse darkening of
the entire iris although nodular forms may occur.
• Ophthalmic signs which increase the index of suspicion that an iridal pigmentary change represents a diffuse iris melanoma,
rather than benign melanosis include: the presence of iridal thickening or mass lesions, dyscoria, anisocoria, concurrent
uveitis or intra-ocular haemorrhage, and free pigment in the anterior chamber or pigment accumulation in the iridocorneal
angle (+/- secondary glaucoma).
• In the early stages, diffuse iris melanoma differentiation from benign melanosis may be difficult, and close monitoring of the
ophthalmic changes is advised (serial photographs useful).
• Fine needle aspiration biopsy (FNAB) from the iris is usually unrewarding in distinguishing iris melanoma from melanosis
but small “snip” biopsies may be useful if the pigmentary change affects the pupillary zone of the iris.

• Primary post traumatic intraocular sarcoma is thought to originate from lens epithelial cells following lens trauma. The
intraocular mass lesion may be visible ophthalmoscopically, or ultrasonographically in cases where uveitis or intra-ocular
haemorrhage obscures examination. These tumours may invade locally, (e.g. optic nerve/ chiasma) or metastasize to distant
sites. Therefore pre-operative imaging to determine any local and/or systemic involvement of the tumour is indicated if there
is an index of suspicion for this disease (e.g. elderly cat with chronic unilateral uveitis, evidence of an intra-ocular mass and
a history or clinical evidence of previous ocular trauma (e.g. corneal scar, synechia)).

• Ocular involvement in feline lymphoma is common and often precedes systemic manifestations. These cases may present
with pale intra-ocular mass lesions or in the earlier stages, more subtle nodular iris lesions may be evident. Cytology on aque-
ocentesis samples or FNAB from an anterior uveal mass may be rewarding in these cases although the diagnosis is usually
achieved by sampling of other affected organs or lymph nodes.

• The presence of large capillary beds within the uveal tract makes it a potential site for haematogenous metastasis from any
distant neoplasia. One particular neoplasm which appears to have a characteristic ophthalmic presentation is bronchogenic
carcinoma.
• An ischaemic chorioretinopathy occurs due to invasion of the choroidal vasculature leading to wedge shaped areas of tan
discolouration within the tapetal fundus and serous sub-retinal exudation.
• These cats present with unilateral or bilateral blindness and may also have painful ischaemic necrosis of the distal extremi-
ties.
• Diagnosis in such cases relies on biopsy of the primary or non- ocular metastatic lesions.
• The discussion so far has considered causes of feline uveitis in which the clinical presentation either identifies, or is highly
suggestive of, a particular causation.
• In other cases further investigation of causes of endogenous uveitis including infectious, immune- mediated and vascular dis-
ease, is indicated.
• The minimum data base obtained should be a complete blood count, serum biochemistry profile, urinalysis, thoracic radi-
ography and abdominal ultrasound.
• Selection of additional diagnostic tests may be affected by other clinical findings (e.g. coagulation studies and blood pres-
sure assessment if intra-ocular haemorrhage is present or vessel tortuosity is identified) and knowledge of the diseases
endemic in a given region (e.g. blastomycosis, histoplasmosis and leishmaniasis not reported in the U.K. (?Italia) but could
occur in a cat which has traveled from endemic areas).

• In the UK, testing for Toxoplasma gondii, feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), feline coron-
avirus and Bartonella henselae are recommended.
• Aqueocentesis and vitreocentesis may be considered in cases in which granuloma formation is evident (e.g. mycotic or
mycobacterial infection).
• Vitreocentesis is more likely to yield a diagnosis even if there is anterior chamber involvement.
• Cryptococcus neoformans is the most commonly reported feline mycotic infection.
• Frequent sites of infection are the nasal passages, skin, and central nervous system: granulomatous uveitis may also be a fea-
ture.
• The diagnosis of cryptococcosis can be established on the basis of cytological identification of the organism aspirated from
affected tissue (non-ocular in most cases), and detection of cryptococcal antigen in serum, aqueous or vitreous using latex
agglutination kits.

SCIVAC International Congress 2011 - Rimini, Italy


142
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

CLINICAL CASE: EB 29 mo FE exotic

• History
• Vaccinated (FHV-1, FIE, FCV and FeLV)
• flea-tick control good,
• indoor/outdoor, single cat household
• hunts and fights
• has not travelled away from Italia
• previous medical history (PMH) – no abnormalities
• previous ophthalmic history (POH) – no abnormalities

• Physiclal examintion –no abnormalities

What abnormalities can you see?……………………………………………………………………………………………


…………………………………………………………………………………………………………………………………
What is your clinical diagnosis?……………………………………………………………………………………………
…………………………………………………………………………………………………………………………………
What other ophthalmic findings could be seen with this condition?………………………………………………………
…………………………………………………………………………………………………………………………………
Is this likely to represent a case of endogenous or exogenous uveitis?……………………………………………………
…………………………………………………………………………………………………………………………………
What initial investigations would you recommend?………………………………………………………………………
…………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………
What infectious diseases would you test for in ITALIA?…………………………………………………………………
…………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………
What is the most frequently reported feline mycotic infection, at what sites does it often cause disease and how is it
diagnosed?……………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………

SCIVAC International Congress 2011 - Rimini, Italy


143
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

What abnormalities can you see? Keratic precipitates, iritis, rubeosis irides
What is your clinical diagnosis? Anterior uveitis
What other ophthalmic findings may occur with this disease?
Anterior changes: aqueous flare, ciliary flush, iris swelling (and darkening), miosis, corneal oedema, hyphaema and hypopyon
Posterior changes: choroidal and retinal inflammation including exudates, haemorrhage and retinal detachment.
Is this likely to represent a case of endogenous or exogenous uveitis?
Endogenous: the majority of feline uveitis cases will have no history or clinical findings suggestive of an exogenous cause and
consideration of the endogenous causes of uveitis including infectious, immune-mediated and vascular diseases (Table 1).
What initial investigations would you recommend?
Minimum data base:
• complete blood cell count
• serum biochemistry profile
• urinalysis
• thoracic radiography
• abdominal ultrasound
Selection of additional diagnostic tests may be affected by other clinical findings (e.g. coagulation studies and blood pres-
sure assessment if intra-ocular haemorrhage is present or retinal vascular tortuosity?) and knowledge of local endemic dis-
eases.
What infectious diseases would you test for in Italia? Toxoplasma gondii, feline leukemia virus (FeLV), feline immunod-
eficiency virus (FIV), feline infectious peritonitis virus (FIP) and Bartonella henselae are recommended.
Aqueocentesis and vitreocentesis may be considered in cases in which granuloma formation is evident (e.g. mycotic or
mycobacterial infection).
Vitreocentesis is more sensitive even if there is AC involvement.
What is the most frequently reported feline mycotic infection, at what sites does it often cause disease and how is it
diagnosed?
Cryptococcus neoformans is the most commonly reported feline mycotic infection. Frequent sites of infection are the nasal
passages, skin, and central nervous system: granulomatous uveitis may also be a feature.
The diagnosis can be established on the basis of cytology (aspirates from affected tissue (non-ocular in most cases)), and
detection of cryptococcal antigen in serum, aqueous or vitreous using latex agglutination kits.

• Toxoplasmosis
• Causally linked with feline uveitis: uveitis has been induced in cats following inoculation with T. gondii.
• Pathology may occur due top replication within retina (direct cytotoxicity → necrosis & granulomata)
OR
• Immune mediated mechanisms → T gondii + immune complex deposition
• Within uvea or antigenaemia stimulating T. gondii specific intraocular lymphocytes

• Clinical disease
• In people typical retino-choroiditis lesions = most common
• This occurs following reactivation of dormant tissue phase (bradyzoites)
• In cats the entire uvea may be involved - usually anterior uveitis
• ? Role of reactivation of dormant phase

• Serological testing of cats for T. gondii should include:


• T gondii -specific IgM
↑ by approximately ~ 2wk post infection
Negative by 16 wk but may persist longer in some cases
Not all cases develop IgM

• T gondii –specific IgG


IgG may not ↑ until ~ 4 wk post infection
May remain elevated for years

• Serological evidence of recent of reactivated infection?


• High T. gondii-specific IgM titres (ELISA for IgM > 256)
Titres vary between labs i.e. for lab (x) an IgM > 64 may indicate active infection
Narrow window for detection ↑ IgM titre so failure to show ↑ doesn’t rule out recent infection

SCIVAC International Congress 2011 - Rimini, Italy


144
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS
OR
• Increasing (4 fold or greater) T. gondii-specific IgG titres in the serum over 2-3 wk
• However since seropositivity to, T. gondii-specific IgM / IgG can occur in clinically normal cats they may not correlate to
clinical ocular disease in an individual cat
• Aqueous humour testing has been used to try and improve the specificity of testing for ocular toxoplasmosis
• Calculation of indices which indicate evidence of intra-ocular T. gondii-specific immunoglobulin production (e.g. Gold-
mann–Witmer coefficient (C-value))
→ c values > 1 suggestive of local Ab production
→ c values > 8 strong evidence
BUT
→ ocular T gondii -specific Ig increased in experimentally inoculated healthy cats
and chronically infected cats by non-specific immune stimulation (c values > 1)
→ therefore the “c” value may not improve the positive predictive value (PPV) of testing for
T. gondii involvement in feline ocular disease
→ Intraocular T. gondii specific IgM may be a better marker for clinical disease
• Molecular tests for T. gondii antigens or DNA in the aqueous humour assist in the diagnosis of T. gondii induced uveitis

• Feline leukaemia virus (FeLV)


• Initial testing for FeLV is usually performed using an “in-house” ELISA (enzyme-linked immunosorbent assay) or ICGA
(immunochromatographic assay) to detect soluble protein (FeLV – p27) in the plasma or serum.
• This indicates FeLV viral infection but does not distinguish transient or permanent viraemia.
• A confirmatory test such as a different type of ELISA or ICGA testing kit or an IFA (immunofluorescent antibody assay) is
necessary to confirm the positive result.
• A positive IFA detects FeLV p27 antigen within WBCs and is likely to signify permanent FeLV infection.
• Testing should be repeated at 12 weeks to confirm a positive viraemia.
• A direct causal link between FeLV and uveitis has not been established.
• Therefore even in a persistently viraemic patient, direct causation between FeLV and feline uveitis cannot be assumed.
• Ocular involvement in feline lymphoma is common and probably represents metastasis of neoplastic cells to the uveal tract
(haematogenously).

• Feline immunodeficiency virus (FIV)


• Causal link? - uveitis associated with FIV in both experimentally & naturally infected cats although direct causation not
proven
• Proposed mechanisms: direct viral damage to tissue, immune mediated disease and predisposing to opportunistic infection
and a possible association with ocular lymphoma
• As with FeLV, initial testing for FIV is usually performed using an “in-house” ELISA or ICGA to detect antibodies to FIV
in the serum.
• Positive results need to be confirmed using an alternative testing methodology such as IFA or western blot (which also detect
antibodies to FIV) or PCR.
• In one study all FIV-seropositive cats with uveitis were also seropositive for T. gondii emphasizing the need to screen for
multiple infectious agents.

CLINICAL CASE: 29 mo FE exotic – 2 wk hx of cloudiness affecting the right eye

FeLV ELISA “Snap®” test

TEST +

SCIVAC International Congress 2011 - Rimini, Italy


145
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

Using an “in house” ELISA for the P27 antigen the patient tests + for FeLV.

Does this result mean the cat is persistently infected with FeLV?
…………………………………………………………………………………………………………………………………
Does serological evidence mean FeLV is the cause of the uveitis in this cat?
…………………………………………………………………………………………………………………………………
How would you confirm persistent infection in this case?
…………………………………………………………………………………………………………………………………

Using an “in house” ELISA for the P27 antigen the patient tests + for FeLV…

Does this result mean the cat is persistently infected with FeLV?
Initial serological testing for FeLV using an “in-house” ELISA or ICGA detect soluble protein (FeLV p27) in the plasma or
serum.
This does not distinguish between transient or permanent viraemia
Furthermore no test has a 100 % sensitivity and specificity, and the reliability of a test (i.e. its predictive value) decreases
as the prevalence of the disease in the population decreases.

Does serological evidence mean FeLV is the cause of the uveitis in this cat?
No - serological tests for infectious diseases indicate exposure (as may occur in healthy cats) to an infectious agent but do
not definitively establish a direct causal link between the infectious agent & uveitis in an individual cat.
Furthermore a direct causal link between FeLV and uveitis has not been established.
FeLV is reported to occur at a higher prevalence in cats with anterior uveitis suggesting some role in some of these cases
BUT FeLV replication within the uveal tract has not been demonstrated. Therefore even in a persistently viraemic patient,
direct causation between FeLV & feline uveitis cannot be assumed.

How would you confirm persistent infection in this case?

A confirmatory test such as a different type of ELISA or ICGA testing kit or an IFA (immunofluorescent antibody assay) is
necessary to confirm the positive result. (but this needs to be done after 6? Weeks between both to confirm infection, right?)
A positive IFA detects FeLV p27 antigen within WBCs and is likely to signify permanent FeLV infection

• Feline Herpes Virus (FHV)


• In a study of naturally exposed cats, FHV-1 ocular antibody production was not detected in FHV-1 seropositive normal cats
• In cats for which the cause of uveitis was unknown, 22 of 44 (50%) had FHV-1 C-values >1 documenting ocular antibody
production.
• Recently, we have detected FHV-1 in 11 of 44 (25%) However, FHV-1 (one of 13; 7.8%), DNA can be detected by poly-
merase chain reaction in the aqueous humour of some healthy cats.
• Thus, detection of organism DNA in aqueous humour does not always correlated to clinical disease.

• Feline infectious peritonitis (FIP)


• Diagnosis of FIP induced feline uveitis is hindered because serology does not distinguish between enteric and FIP-inducing
strains of feline coronavirus.
• It is therefore important to interpret the serological findings in conjunction with other parameters to increase the accuracy of
testing.
• In one report a combination of a coronavirus antibody titre >1:160, with concurrent lymphopaenia and hypergammaglobu-
linaemia had a positive predictive value of 88.9% in cases with suspected systemic FIP.

• Bartonella spp.
• The cat is the major persistent reservoir host for numerous Bartonella spp including B. henselae and B. clarridgeiae. There
is increasing evidence that these agents may be involved with feline uveitis, but interpretation of serological findings is dif-
ficult due to the frequency of asymptomatic carriers (in one study 41% of cats were persistently bacteraemic but showed no
clinical signs). In the future testing for Bartonella spp antigens or DNA in the aqueous humour may potentially assist in the
diagnosis of feline bartonellosis.

SCIVAC International Congress 2011 - Rimini, Italy


146
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS
• When performing serological tests for infectious diseases it is important to remember that they indicate exposure to an infec-
tious agent (as may occur in healthy cats) and therefore do not definitively establish a direct causal link between the infec-
tious agent and uveitis in an individual cat. Furthermore no test has a 100 % sensitivity and specificity, and the reliability of
a test (i.e. its predictive value) decreases as the prevalence of the disease in the population decreases.

• In many cases a causal relationship with an infectious agent is not established and immune mediated disease uveiti-
ides are considered

• Immune-mediated (including autoimmune) uveitiides, although probably common in cats (as in other species) are poorly
defined and are likely to represent a significant percentage of cases which are classified as idiopathic.
• The diagnosis is largely one of exclusion.
• In human medicine there are strong associations between an increasing numbers of uveitiides with specific MHC haplotypes;
responses to specific endogenous ocular antigens are now recognized to either initiate or perpetuate uveitis.
• An example of this is cancer-associated retinopathy (CAR) in people, which is thought to be driven at least in part by anti-
bodies against the retinal protein recoverin.
• Feline uveitis may occur in association with non-ocular tumours and some of these may represent immune-mediated para-
neoplastic uveitiides akin to the human CAR syndrome.

• Treatment of uveitis: early - aggressive and prolonged treatment required

• Medical
• Symptomatic topical anti-inflammatory therapy instituted immediately even in those patients with suspected multisystem
disease
• Even if a diagnosis of an infectious agent is eventually made initial anti-inflammatory treatment is still mandatory to save
the integrity of the eye
• Failure to institute prompt therapy may result in numerous adverse sequelae of uveitis, including synechiae, cataract, glau-
coma and phthisis bulbi.
• Systemic therapy includes various combinations of anti-inflammatory, antimicrobial, and specific therapy as determined by
the multisystemic disease
• Topical therapy alone may suffice for mild anterior uveitis, but for severe anterior uveitis and posterior uveitis, systemic ther-
apy is also indicated

• Mydriatic-cycloplegic drugs
• Parasympathetic agents such as atropine induce mydriasis, post synechiae & provide cycloplegia (relieving pain) n.b.more
frequent therapy may be required to induce cycloplegia compared to mydriasis - this explains why ciliary body spasm (pain)
may still exist after the pupil is dilated
• Non-specific anti-inflammatory effect by stabilizing the blood—aqueous barrier, therefore reducing uveitis and facilitating
re-establishment of normal lOPs
• In complicated uveitis cases they must be administered with caution because of chance producing SECONDARY GLAU-
COMA
• Mild uveitis may require therapy with atropine 1% once or twice daily, whereas more severe cases may require more fre-
quent application (e.g., 4-6 times daily)
• Atropine 1% ointment is the treatment of choice for cats
• Side effects of frequent treatment with topical atropine may include decreased tear production, tachycardia, gut motility, &
the potential to precipitate acute glaucoma
• Decreased tear production is a common side effect in the dog and is significant when ulcerative keratitis coexists with uveitis
• 10% phenylephrine can be used for recalcitrant cases when pupillary dilation is difficult to achieve especially if extensive
synechiae have formed
• 10% phenylephrine is not particularly effective in cats compared to dogs and may cause systemic toxicity
• Scopolamine/phenylephrine solution (Murocoll2) may break fibrous adhesions and dilate pupils that are unresponsive to
atropine, because it combines the additive effects of parasympatholytic and sympathomimetic agents
• Efficacy in domestic animals has not been consistently documented

• Suppress Inflammation
• Corticosteroids: TOPICALLY, SUBCONJUNCTIVALLY, SYSTEMICALLY
• Increase cellular membrane integrity, inhibit lysozyme release / reduce the amount of exudate
• Topical corticosteroids -are the primary therapy for patients with anterior uveitis, including those with suspected infectious
disease in an attempt to prevent the possible blinding sequels of uveitis (synechiae, cataract & glaucoma)
• 1% prednisolone acetate and 0.1% dexamethasone acetate penetrate are recommended as they penetrate the intact cornea

SCIVAC International Congress 2011 - Rimini, Italy


147
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS
better and are more potent than other steroid preparations
• An initial application frequency of q 1 to 6 hours may be required with solutions
• When being used longer term in small dogs (toy) and cats – e.g. prednisolone acetate 0.5% may reduce risk of adrenal axis
suppression
*Gentle shake suspension at least 20 times before use
*Elevate the nose ~ 2 minutes after application

• Subconjunctival corticosteroids
• May be administered in select cases as an adjunct to topical therapy
• Triamcinolone acetonide (Vetalog), methylprednisolone acetate (Depo-Medrol), betamethasone (Betasone), and dexametha-
sone (Azium) may be used for subconjunctival injection
• Subconjunctival injection in cases that cannot be treated routinely or chronic cases where treatment difficult or contraindi-
cated

• Systemic corticosteroids
• Much greater caution is required before beginning systemic corticosteroid therapy (esp. when bacteraemia or systemic
mycoses are suspected)
• Corneal ulceration is a contraindication to topical or subconjunctival steroid therapy, but not necessarily to systemic thera-
py
• Start with high doses → e.g. prednisolone 2mg/kg SID – for SEVERE cases or
1 mg/kg for moderate cases and wean slowly as the inflammation subsides

• NSAIDS

• Topical NSAIDS:
• When combined with corticosteroids their therapeutic effects are additive and combination therapy may be beneficial in
refractory cases.
• NSAIDs that have been used topically on the eye include indomethacin (Indocid), flurbiprofen (Ocufen), suprofen (Profena)
and diclofenac (Voltarol)
• Experimental study → 1% suspensions of each drug, the relative blood-aqueous barrier— stabilizing efficacy was:
diclofenac > flurbiprofen > suprofen
• Experimental study using commercially available drug concentrations, the stabilizing efficacy was: 0.03% flurbiprofen >
0.1% diclofenac > 1 % suprofen
• however, in both these studies, the anti-inflammatory effects of diclofenac and flurbiprofen were similar, and both drugs
would appear to be acceptable choices for clinical use in the dog
• the indications and contraindications for topical NSAIDs are suggested to be similar to those for corticosteroids
• flurbiprofen may delay corneal wound healing, but unlike corticosteroids, it does not appear to potentiate collagenase
activity
• flurbiprofen has been safely used to treat eyes with concurrent uveitis and corneal ulceration BUT is contraindicated in ani-
mals with co-existing herpesvirus keratitis.

• Systemic NSAIDs:
• NSAIDs → contraindicated when hyphaema or bleeding tendencies
• Dog → aspirin dosages for uveitis are as high as 20 to 40 mg/kg two times a day, but 10 to 15 mg/kg orally two or three
times a day appears to be effective
• Carprofen has been shown to be an effective at 2 mg/kg orally two times a day
• Carpofen seems to have minimal effect on platelets compared with that of other NSAIDs but hepatotoxicity has been rec-
ognized, particularly in the Labrador retriever
• Aspirin advocate by some as a good option for long-term management of uveitis

• Cats- 10 mg/kg orally every 52 hrs


• Dogs- 10-25 mg/kg orally every 12 hrs

SCIVAC International Congress 2011 - Rimini, Italy


148
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS

CLINICAL CASE: 29 mo FE exotic – 2 wk hx of cloudiness affecting the right eye

FeLV ELISA “Snap®” test

TEST +

Scenario 1: only anterior chamber signs are present

What medication would you prescribe at what dose and for how long?
…………………………………………………………………………………………………………………………………

What is the prognosis for the eye?


…………………………………………………………………………………………………………………………………

Scenario 2: vitritis is present and it is difficult to see the retina

What medication would you prescribe at what dose and for how long?
…………………………………………………………………………………………………………………………………

What is the prognosis for the eye?


…………………………………………………………………………………………………………………………………

• Immunosuppressive drugs

• Azathioprine (Imuran®)
• Mainly in those cases unresponsive to conventional therapy.
• Imuran® → most commonly used in therapy for uveodermatological syndrome in the dog
• Frequent blood, platelet counts & liver enzyme determinations are recommended with initial therapy because of the poten-
tial hepatotoxic / myelosuppressive effects of this drug.
• Initial dosage is 2mg/kg per day for 3 to 5 days, followed by reduction on the basis of blood parameters and response to ther-
apy.

• Cyclosporine
• Immunosuppressive agent that primarily affects T-lymphocyte functions.
• The topical formulation has gained popularity for the treatment of external ocular diseases in the dog (e.g., keratoconjunc-
tivitis sicca), but its relatively poor intraocular penetration after topical application
• 0.2% ophthalmic (Optimmune®).
• 1 or 2% solution prepared in corn oil with the oral solution (Sandimmune®)

SCIVAC International Congress 2011 - Rimini, Italy


149
69° Congresso Internazionale Multisala SCIVAC

Reprinted in IVIS with the permission of SCIVAC Close this window to return to IVIS
®
• Systemic cyclosporine (Atopica )
• can be used in order to control inflammation within the eye
• cyclosporine inhibits the IL-2 that stimulates T lymphocytes and has been used as immunomodulator +/- anti-inflammatory
in different diseases such as: uveodermatologic syndrome, idiopathic uveitis, complicated uveitis post-phacoemulsifica-
tion…
• Should be used with caution in dogs with hepatic and renal disease
• CsA metabolism is reduced (hence plasma concentration increase) with the use of ketoconazol and other izoles, cimetidine,
doxycycline…and also with the use of allopurinol.

• Antimicrobial

• Topical antimicrobial
• antibiotics found in most ophthalmic preparations (i.e., aminoglycosides, bacitracin, polymyxin) do not penetrate the intact
cornea readily; therefore, they would have minimal benefit in therapy for bacterial-mediated uveitis.
• Tetracycline may achieve therapeutic levels in the eye
• chloramphenicol and many topical quinolone antibiotics (e.g. ofloxacin (Exocin®)) penetrate the cornea well

• Systemic antimicrobial
• may be indicated as prophylaxis or specific causative agent
• the blood-aqueous barrier is normally impermeable to many antibiotics, but during active uveitis, the blood aqueous barrier
is compromised and drug permeability enhanced.
• Some drugs penetrate the normal blood—aqueous barrier; these drugs are recommended for empirical therapy:

• Amoxicillin
• Trimethoprim/ sulfadiazine
• Cephalosporin
• Particular antibiotic may be indicated – for example…
→ doxycylcine for ehrlichiosis
→ clindamycin for azithromycin for toxoplasmosis
→ doxycycline and azithromycin for bartonellosis

SCIVAC International Congress 2011 - Rimini, Italy


150

You might also like